DIVERSIFIED HEALTHCARE TRUST (DHC) Stock Analysis
DIVERSIFIED HEALTHCARE TRUST
▾ What's in the 51/100 risk score? (higher = riskier)
Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). It excludes the Altman Z score, whose retained-earnings input this filer does not report separately. See the Financial Health section for the full balance-sheet read.
How to read DHC (REIT)
REITs pay out most of their cash, so judge them on cash distributions and the value of their property — not on earnings or a standard DCF.
-
1
REIT lens (P/AFFO + dividend yield) ↓
Price-to-AFFO and the dividend yield are the real cheap/expensive gauges for real estate.
Standard DCF doesn't fit DHC well — but that's expected for this kind of business. The REIT Valuation Lens below uses the metrics actually used by analysts who value reits. Reverse DCF + Football Field also work as cross-checks.
Riskier than 59% of the stocks we cover
A model trained on every US filing since 2012 — including the 823 companies that went bankrupt or stopped trading under a dollar — ranks each covered stock by its chance of failing in the next year. This is a position among peers, not a prediction about this company alone. Below is what happened to stocks that sat in the same position in past years.
▾ Every band, and what happened to the stocks in it
| Rank band | went bankrupt within 12 months | fell 80% or more (or failed) within 12 months | fell 50% or more (or failed) within 6 months |
|---|---|---|---|
| All covered stocks (average) | 0.59% | 4.21% | 8.51% |
| Finance (sector average) | 0.13% | 1.25% | 3.09% |
| riskiest 1% | 16.4% of 1,749 | 33.0% of 1,998 | 45.5% of 2,239 |
| next 2% (97-99) | 5.9% of 3,360 | 24.9% of 3,985 | 38.2% of 4,461 |
| next 2% (95-97) | 3.4% of 3,409 | 21.2% of 3,984 | 33.8% of 4,462 |
| next 5% (90-95) | 1.6% of 8,443 | 15.1% of 9,965 | 27.3% of 11,155 |
| next 15% (75-90) | 0.8% of 25,328 | 8.5% of 29,884 | 17.8% of 33,459 |
| next 25% (50-75) ← this stock | 0.2% of 36,310 | 2.7% of 49,810 | 6.2% of 55,771 |
| safest half | <0.1% of 92,256 | 0.5% of 99,617 | 2.1% of 111,538 |
Counts are stock-quarters 2012–2025, scored each year by a model that had not seen that year. The rank is recomputed from each company's latest filing (this one: 2026-05-05); table generated 2026-09-17. Calibrated one-year odds for this stock alone: bankruptcy 0.1%, 80%+ fall 1.0%, 50%+ fall in six months 2.8% — treat these as rougher than the band counts; the model overstates the middle of the range.
What this is not. It is not a trade. We tested shorting these names and buying puts on them at real option prices (2010–2025): every version lost money, because the market already prices the distress and the survivors squeeze. A high rank is a reason to read the filings and to size a position for the chance of a total loss — not a reason to bet against the company. A low rank says the balance sheet and the market are calm; it says nothing about whether the price is sensible.
How does DHC stack up against its closest peers?
We take the 8 same-industry companies most similar to DHC (similar size) and check what investors are paying for each dollar of their revenue (or profits). If DHC is much more expensive on the same yardstick, that's a red flag — unless you have a specific reason it deserves a premium. For a leveraged business, EV/EBIT and FCF yield (both in the table) are usually more reliable than EV/Sales, because revenue multiples ignore differences in margins and debt.
▾ What's "EV / Sales" in plain English?
EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.
EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).
p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.
| EV / SalesEV / Sales — For every $1 of yearly revenue, this is how many dollars investors pay to own the whole business (including debt). Why it matters: Works for pre-profit growth companies where P/E and FCF don't apply. The most apples-to-apples cross-company multiple because it ignores accounting choices. Reference: 1–3x for mature companies · 4–10x for software/SaaS · 10–20x for hypergrowth · >20x is rare and demanding Full explanation → |
2.7x / 7.6x / 12.5x |
Bold middle number = median peer. Half the peers trade above it, half below. Computed over 8 same-industry peers; implausible multiples excluded.
⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.
▾ View peer list (8)
| Ticker | Company | Industry | Mcap | EV/Sales | EV/GP | EV/EBIT | FCF Yield |
|---|---|---|---|---|---|---|---|
| SMA | SmartStop Self Storage REIT, Inc. | REITs | $1.7B | 6.2x | 10.0x | 29.3x | 4.3% |
| PEB | Pebblebrook Hotel Trust | REITs | $1.7B | 2.6x | — | 88.0x | 0.3% |
| SILA | Sila Realty Trust, Inc. | REITs | $1.7B | 8.5x | — | — | 5.3% |
| RLJ | RLJ Lodging Trust | REITs | $1.5B | 2.7x | — | — | 6.3% |
| PMTV | PennyMac Mortgage Investment Trust | REITs | $2.2B | 12.4x | — | — | 6.3% |
| PMTU | PennyMac Mortgage Investment Trust | REITs | $2.2B | 12.5x | — | — | 6.3% |
| PMTW | PennyMac Mortgage Investment Trust | REITs | $2.2B | 12.6x | — | — | 6.2% |
| RYN | RAYONIER INC | REITs | $2.4B | 6.8x | — | 39.5x | 22.6% |
Real-estate-specific metrics
REITs are valued on AFFO (Adjusted Funds from Operations) and dividend yield, not DCF. Reported depreciation isn't a real cash cost for real estate — properties typically hold or appreciate. The metrics below are the industry-standard yardsticks.
Note: Depreciation & Amortization line not available — using FCF/share as AFFO proxy. Directionally correct but understates true AFFO (true AFFO adds back D&A and subtracts only maintenance CapEx; FCF subtracts all CapEx).
Quality & solvency checks
Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
REITs deliberately carry high leverage backed by long-life real estate and pay out 90%+ of taxable income — both inputs that Altman Z flags as distress. See the REIT Valuation Lens above for P/AFFO, dividend yield and payout ratio.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
Piotroski F's checks (operating cash flow, gross-margin trend, current ratio, asset turnover) assume an industrial cost structure, so they misread asset-heavy or financial businesses like this one — a healthy REIT, utility, pipeline, BDC/fund or holding company can score low for reasons that aren't weakness. See the sector lens above for the metrics that actually matter.
Plain English: the company holds about $105M in cash and is burning roughly $20M/year in operations. At that pace, the cash lasts 5.4 yrs before it must raise capital (diluting shareholders), take on debt, or cut spending.
Assumes constant burn and ignores financing/asset sales. For pre-profit biotech and growth companies, this matters more than a DCF — a great drug pipeline is worthless if they run out of money before approval.
What if you assume different inputs?
Here's where we land — and what happens if you change the assumptions. Drag the sliders to set your own Discount RateDiscount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
Full explanation → (the annual return you demand for single-stock risk) and terminal growth; the value updates live so you can see whether the stock looks cheaper or richer. The discount rate starts at 10.0%, the figure our model used for DHC. Open Advanced to also change beta, growth and the rate path.
Note: no headline intrinsic value is published for this stock (the valuation is held for a data-quality reason — see the notes above). The calculator below is a what-if tool: the values it produces are your assumptions played out, not our estimate.
A full intrinsic value isn't shown for DHC because the valuation is currently held for a data-quality reason (see the guardrail notes above). The reverse-DCF reading still works — it needs only the price and cash flow — but we won't publish a forward value until the underlying data passes our checks.
—
⚙ Advanced — tinker with every input (beta, growth, rate path, margin → full intrinsic value)
A standard DCFDCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation → valuation is not meaningful for Diversified Healthcare Trust due to its negative operating cash flow and net income in recent periods. Investors are likely focused on the company's ability to stabilize its operations and return to profitability, rather than current cash flow. The primary quantifiable risk is the rising long-term debt, which has increased from $0M to $2444M.
As of 3 months ago
Anatomy of a share
What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.
What's free cash flow / what do these mean?
Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.
Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.
Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.
Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.
What you actually need to decide
Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.
- Return to positive operating cash flow
- Stabilization or reduction of long-term debt
- Improvement in net income profitability
The trend, in plain numbers (FY2024 → FY2025, latest reported)
Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.
- Revenue grew +3% to $1.54B.
- Still unprofitable at -$285.9M — loss narrowing.
- Free cash flow is negative at -$23.0M — the cash burn widened vs last year.
Management & Leadership
Diversified Healthcare Trust is led by President and CEO Jennifer Francis, who has been in her role since 2018. She also serves as a Managing Trustee. Adam Portnoy is the Managing Trustee and has been involved with the company for many years.
What They Make
Diversified Healthcare Trust is a real estate investment trust (REITREIT (Real Estate Investment Trust) — A company that owns income-producing real estate and is required to pay out about 90% of its profit to shareholders as dividends.
Why it matters: Because they pay out almost everything, REITs are judged on the cash they distribute (price-to-AFFO and dividend yield), not on ordinary earnings — a normal P/E or DCF misleads here.
Reference: Dividend yields often 3–6%; valued on price-to-AFFO, not P/E.
Full explanation →) that owns a portfolio of healthcare-related properties, including senior living communities, medical office buildings, and life science properties, which it leases to healthcare operators and tenants.
End Markets
Revenue Drivers
Why Is It Priced Like This?
Why Customers Pay
What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.
The market is likely pricing DHC based on expectations for a turnaround in its core real estate portfolio and a return to consistent profitability, given its negative net income and operating cash flow. Investors are betting on the future value of its healthcare properties and potential for revenue stabilization, which has been roughly flat at 2.7%/yr over four years.
Business Model & Valuation
How They Make Money
Dividend Discount
REIT (REITs): dividend discount model - GAAP earnings distort REIT valuations.
Show advanced inputs
What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project net interest income and fee-income lines independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.
Maturity & Competitive Position
Moat Signals
Revenue has been roughly flat, increasing from $1383M to $1538M over four years.
Geography & Markets
Diversified Healthcare Trust operates primarily in the United States, owning a portfolio of healthcare properties across various states. Specific geographic mix percentages are not available from current data sources.
Geographic Risks
Market Signals
These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation → (14)51.3NeutralMomentum is balanced — neither overbought nor oversold.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →BearishLine below signalThe fast trend is below the slow trend — short-term momentum is currently downward.
Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.
QUALITY
Data Quality & Risk Flags (5 notes — click to expand/collapse)
Guardrail Notes (5)
- Dividend derived from cash-flow statement ($0.04/yr; SEC has no per-share dividend feed).
- Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.
- Dividend data sparse; DDM using estimated yield. Confidence reduced.
- Extreme valuation (P/IV withheld — see the note above); output dominated by data/units issue (often a multi-class share-count mismatch). Suppressed.
- DATA UNAVAILABLE: per-share values suppressed due to missing/unreliable shares data.
FINANCIALS
Financial Statements (5-year tables — click to expand)
From DIVERSIFIED HEALTHCARE TRUST's SEC filings (EDGAR).
Income (5yr)
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | 1.5B | -285.9M | $-1.19 |
| 2024 | 1.5B | -370.3M | $-1.55 |
| 2023 | 1.4B | -293.6M | $-1.23 |
| 2022 | 1.3B | -15.8M | $-0.07 |
| 2021 | 1.4B | 174.5M | $0.73 |
Cash Flow (5yr)
Capital expenditure isn't tagged in this filer's machine-readable data (the CapEx column shows "—"). The free-cash-flow column is therefore operating cash flow less stock-based compensation only — an upper bound on true owner earnings, not the real figure. Companies that report capex under a custom label (some large IFRS filers do) look better here than they are.
| Year | Operating CF | CapEx | − SBC & adj. | Free Cash Flow |
|---|---|---|---|---|
| 2025 | -19.6M | — | 3.4M | -23.0M |
| 2024 | 112.2M | — | 2.7M | 109.5M |
| 2023 | 10.5M | — | 1.8M | 8.6M |
| 2022 | -40.4M | — | 1.7M | -42.1M |
| 2021 | -63.3M | — | 2.0M | -65.3M |
How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: -19.6M − — − 3.4M (SBC & adj.) = -23.0M. This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a TTM dividend, not this single year.
Balance Sheet
| Total Assets | 4.4B |
| Total Liabilities | 2.7B |
| Equity | 1.7B |
| Total Debt | 2.4B |
Similar companies worth a look
Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.